Changes in bone markers in children with asthma during inhaled budesonide and nedocromil treatments

Acta Paediatrica, International Journal of Paediatrics

Volumn 85, Issue 10, 1996, Pages 1176-1180

  Sorva, R ^a,e   Tahtela R ^a,b   Turpeinen, M ^a   Juntunen Backman, K ^a   Haahtela, T ^a   Risteli, L ^c   Risteli, J ^c   Sorva, A ^d  

^a UNIVERSITY OF HELSINKI   (Finland)

^b Yhtyneet Laboratoriot Oy   (Finland)

^c UNIVERSITY OF OULU   (Finland)

^d Malmi Hospital   (Finland)

^e NONE   (Finland)

Author keywords

Asthma; Bone turnover; Budesonide; Collagen; Nedocromil

Indexed keywords

BUDESONIDE; COLLAGEN; NEDOCROMIL; NEDOCROMIL SODIUM; OSTEOCALCIN;

ARTICLE; ASTHMA; BONE METABOLISM; BONE TURNOVER; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ENZYME IMMUNOASSAY; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION; MALE; PRIORITY JOURNAL;

EID: 0029917370     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.1996.tb18224.x     Document Type: Article

References (26)

1. Nicolaizik WH, Marchant JL, Preece MA, Warner JO. Endocrine and lung function in asthmatic children on inhaled corticosteroids. Am J Respir Crit Care Med 1994;150:624-8
2. Wolthers OD, Pedersen S. Growth of asthmatic children during treatment with budesonide: a double blind trial. BMJ 1991;303:163-5
3. Douill IJM, Freezer NJ, Holgate ST. Growth of prepubertal children with mild asthma treated with inhaled beclomethasone dipropionate. Am J Respir Crit Care 1995;151:1715 9
4. Turpeinen M, Sorva R, Juntunen-Backman K. Changes in carbohydrate und lipid metabolism in children with asthma inhaling budesonide. J All Clin Immunol 1991;88:384 9
5. Sorva R, Turpeinen M, Juntunen-Backman K, Karonen S-L, Sorva A. Effect of inhaled budesonide on serum markers of bone metabolism in children with asthma. J All Clin Immunol 1992;90:808 15
6. Smith R. Corticosteroids and osteoporosis. Thorax 1990;45:573 8
7. Risteli L, Risteli J. Biochemical markers of bone metabolism. Ann Med 1993;25:385 93
8. Seyedin SM, Kung VT, Duniloff YN, Hesley RP, Gomez B, Nielsen LA et al. Immunoassay for urinary pyridinoline: the new marker of bone resorption. J Bone Miner Res 1993;8:635 41
9. Seibel MJ, Robins SP, Bilezikian JP. Urinary pyridium crosslinks of collagen. Specific markers of bone resorption in metabolic bone disease. Trends Endocrinol Metab 1992;3:263 70
10. Hanson DA, Weis MAE, Bollen A-M, Maslan SL, Singer FR, Eyre DR. A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res 1992;7:1251 8
11. Eriksen EF, Charles P, Melsen F, Mosekilde L, Risteli L, Risteli J. Serum markers of type I collagen formation and degradation in metabolic bone diseuse: correlation with bone histomorphometry. J Bone Miner Dis 1993;8:127 32
12. Delmas PD, Schlemmer A, Gineyts E, Riis B, Christiansen C. Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis. J Bone Min Res 1991;6:639 44
13. Trivedi P, Risteli J, Risteli L, Hindmarsh PC, Brook CGD, Mowat AP. Serum concentration of the type I and III procollagen propeptides as biochemical markers of growth velocity in healthy infants and children and in children with growth disorders. Pediatr Res 1991;30:276 80
14. Autio P, Risteli J, Kiistala U, Risteli L, Karvonen J, Oikarinen A. Serum markers of collagen synthesis and degradation in skin diseases. Altered levels in diseases with systemic manifestation and during sytemic glucocorticoid treatment. Arch Derm Res 1993;285:322 7
15. Wolthers OD, Juul A, Hansen M, Muller J, Pedersen S. The insulin-like growth factor axis and collagen turnover during prednisolone treatment. Arch Dis Child 1994;71:409 13
16. Sorva R, Tolppanen EM, Lankinen S, Perheentupa J. Growth evaluation: parent- and child-specific height standards. Arch Dis Child 1989;64:1483 7
17. Sorva R, Turpeinen M. Asthma, glucocorticoids und growth. Ann Med 1994;26:309 14
18. Lems WF, Jacobs JWG, Van Den Brink HR, van Rijn HJM, Bijlsma JWJ. Transient decrease in osteocalcin and markers of type I collagen turnover during high-dose corticosteroid pulse therapy in rheumatoid arthritis. Br J Rheumatol 1993;32:787 9
19. Wolthers OD, Juul A, Hansen M, Muller J, Pedersen S. The insulin-like growth factor axis and collagen turnover in asthmatic children treated with inhaled budesonide. Acta Paediatr Scand 1995;84:393 7
20. Smedsrod B, Melkko J, Risteli L, Risteli J. Circulating C-terminal propeptide of type I procollagen is cleared mainly via the mannose receptor in liver endothelial cells. Biochem J 1990;271:345 50
21. Cowan HB, Vick S, Conary JT, Shepherd VL. Dexamethasone up-regulates mannose receptor activity by increasing mRNA levels. Arch Biochem and Biophysics 1992;296:314 20
22. 2-terminal propeptides of type I and III procollagcn is a physiological function of the scavenger receptor in liver endothelial cells. J Exp Med 1994;179:405 12
23. König P, Hillman L, Cervantes CI. Bone metabolism in children with asthma treated with inhaled beclomethasone dipropionate. J Paediatr 1993;122:219 26
24. Manolagas SC, Jilka RL, Bone marrow. cytokines and bone remodeling. N Engl J Med 1995;332:305 11
25. Baraldi E, Bollini MC, De Marci A, Zacchello F, Effect of beclomethasone dipropionate on bone mineral content assessed by X-ray densitometry in asthmatic children: a longitudinal evaluation. Eur Respir J 1994;7:710 4
26. Kinberg KA, Hopp RJ, Biven RE, Gallagher JC. Bone mineral density in normal und asthmatic children. J Allergy Clin Immunol 1994;94:490 7